Lithium aspartate was chosen specifically over lithium carbonate due to its availability as a dietary supplement and the lower risks of adverse effects, including cancer risk, seen with other ...

Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction. JAMA Network Open , 2024; 7 (10): e2436874 DOI: 10.1001/jamanetworkopen.2024.36874 Cite This Page : ...

He notes that it is possible the randomized controlled trial was ineffective because the dose of lithium aspartate that was used was too low. “The take-home message is that very low dose lithium ...

A small UB clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID; however, a supplemental ...

In the present study, researchers investigated the effects of lithium aspartate on PCC cognitive dysfunction and fatigue. This randomized, placebo-controlled, double-blind, clinical trial was ...

Low-dose lithium aspartate did not improve fatigue and cognitive dysfunction symptoms in long COVID. A small dose-finding study suggested higher doses might be effective, but a new trial is needed.

But all may not be lost: Three of the patients went on to complete an extended "dose-finding" study, and they did achieve reductions in fatigue and brain fog if they took lithium aspartate at a ...

Based on this single case, Guttuso became interested in lithium aspartate as a potential treatment for long COVID and recommended it to other such patients. According to Guttuso, 9 of 10 long COVID ...

Lithium aspartate at 10-15 mg/d is ineffective for treating cognitive dysfunction and fatigue in long COVID, but higher doses may offer potential benefits based on a small follow-up study.

A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID ...

As Guttuso explained, he recommended lithium aspartate at 5 to 15 milligram (mg) daily doses to 10 patients, and nine claimed to see their fatigue and brain fog ease. That prompted him to consider ...

A small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID ...